{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T14:55:56Z","timestamp":1695480956252},"reference-count":51,"publisher":"Impact Journals, LLC","issue":"40","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,10,4]]},"DOI":"10.18632\/oncotarget.11462","type":"journal-article","created":{"date-parts":[[2016,8,21]],"date-time":"2016-08-21T03:58:37Z","timestamp":1471751917000},"page":"64743-64756","source":"Crossref","is-referenced-by-count":8,"title":["Expression of non-secreted IL-4 is associated with HDAC inhibitor-induced cell death, histone acetylation and c-Jun regulation in human gamma\/delta T-cells"],"prefix":"10.18632","volume":"7","author":[{"given":"Jaydeep","family":"Bhat","sequence":"first","affiliation":[{"name":"Institute of Immunology, Christian-Albrechts-University, Kiel, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justyna","family":"Sosna","sequence":"additional","affiliation":[{"name":"Institute of Immunology, Christian-Albrechts-University, Kiel, Germany"},{"name":"Current address: Department of Molecular Biology and Biochemistry, University of California-Irvine, Irvine, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Fritsch","sequence":"additional","affiliation":[{"name":"Institute of Immunology, Christian-Albrechts-University, Kiel, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elgar Susanne","family":"Quabius","sequence":"additional","affiliation":[{"name":"Institute of Immunology, Christian-Albrechts-University, Kiel, Germany"},{"name":"Department of Otorhinolaryngology, Head and Neck Surgery, Christian-Albrechts-University, Kiel, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Sch\u00fctze","sequence":"additional","affiliation":[{"name":"Institute of Immunology, Christian-Albrechts-University, Kiel, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Zeissig","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Christian-Albrechts-University, Kiel, Germany"},{"name":"Current address: Department of Medicine I, University Medical Center Dresden, Technical University Dresden, Dresden, Germany"},{"name":"Current address: Center for Regenerative Therapies Dresden (CRTD), Technical University Dresden, Dresden, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole","family":"Ammerpohl","sequence":"additional","affiliation":[{"name":"Institute of Human Genetics, University Medical Center Schleswig-Holstein Kiel, Christian-Albrechts-University, Kiel, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter","family":"Adam","sequence":"additional","affiliation":[{"name":"Institute of Immunology, Christian-Albrechts-University, Kiel, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter","family":"Kabelitz","sequence":"additional","affiliation":[{"name":"Institute of Immunology, Christian-Albrechts-University, Kiel, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,8,20]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0014-5793(03)00483-6","article-title":"Microbial isoprenoid biosynthesis and human gammadelta T-cell activation","volume":"544","author":"Jomaa","year":"2003","journal-title":"FEBS letters"},{"issue":"2","key":"2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1084\/jem.20021500","article-title":"Human T-cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells","volume":"197","author":"De Libero","year":"2003","journal-title":"The Journal of experimental medicine"},{"issue":"3","key":"3","doi-asserted-by":"crossref","first-page":"e23304","DOI":"10.4161\/onci.23304","article-title":"Human Vdelta2 versus non-Vdelta2 gammadelta T-cells in antitumor immunity","volume":"2","author":"Wesch","year":"2013","journal-title":"Oncoimmunology"},{"issue":"6","key":"4","doi-asserted-by":"crossref","first-page":"e1006088","DOI":"10.1080\/2162402X.2015.1006088","article-title":"gammadelta T-cells and epigenetic drugs: A useful merger in cancer immunotherapy?","volume":"4","author":"Kabelitz","year":"2015","journal-title":"Oncoimmunology"},{"issue":"2","key":"5","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1006\/cimm.2001.1850","article-title":"Differentiation of resting human peripheral blood gamma delta T-cells toward Th1- or Th2-phenotype","volume":"212","author":"Kabelitz","year":"2001","journal-title":"Cellular immunology"},{"issue":"12","key":"6","doi-asserted-by":"crossref","first-page":"7268","DOI":"10.4049\/jimmunol.1000600","article-title":"Cytokine requirements for the differentiation and expansion of IL-17A- and IL-22-producing human Vgamma2Vdelta2 T-cells","volume":"184","author":"Morita","year":"2010","journal-title":"Journal of immunology"},{"issue":"7","key":"7","doi-asserted-by":"crossref","first-page":"e41940","DOI":"10.1371\/journal.pone.0041940","article-title":"IL-21 regulates the differentiation of a human gammadelta T-cell subset equipped with B cell helper activity","volume":"7","author":"Dieli","year":"2012","journal-title":"PloS one"},{"issue":"10","key":"8","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1007\/s00018-013-1467-1","article-title":"Phenotype and regulation of immunosuppressive Vdelta2-expressing gammadelta T-cells","volume":"71","author":"Wesch","year":"2014","journal-title":"Cellular and molecular life sciences"},{"issue":"6765","key":"9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/47412","article-title":"The language of covalent histone modifications","volume":"403","author":"Allis","year":"2000","journal-title":"Nature"},{"issue":"4","key":"10","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","article-title":"Chromatin modifications and their function","volume":"128","author":"Kouzarides","year":"2007","journal-title":"Cell"},{"issue":"10","key":"11","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1158\/1541-7786.MCR-07-0324","article-title":"Histone deacetylase inhibitors: overview and perspectives","volume":"5","author":"Marks","year":"2007","journal-title":"Molecular cancer research"},{"issue":"7","key":"12","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s40263-014-0167-1","article-title":"Efficacy and safety of intravenous valproate for status epilepticus: a systematic review","volume":"28","author":"Brigo","year":"2014","journal-title":"CNS drugs"},{"issue":"1","key":"13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1172\/JCI69738","article-title":"New and emerging HDAC inhibitors for cancer treatment","volume":"124","author":"Johnstone","year":"2014","journal-title":"The Journal of clinical investigation"},{"issue":"3","key":"14","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1158\/0008-5472.CAN-03-0799","article-title":"Histone deacetylase is a target of valproic acid-mediated cellular differentiation","volume":"64","author":"Klein","year":"2004","journal-title":"Cancer research"},{"issue":"1","key":"15","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cellimm.2015.01.019","article-title":"Modulation of human gamma\/delta T-cell activation and phenotype by histone deacetylase inhibitors","volume":"296","author":"Kabelitz","year":"2015","journal-title":"Cellular immunology"},{"issue":"4","key":"16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/1097-0320(20001201)41:4<261::AID-CYTO4>3.0.CO;2-S","article-title":"Expression of interleukin-4 in apoptotic cells: stimulation of the type-2 cytokine by different toxins in human peripheral blood mononuclear and tumor cells","volume":"41","author":"Bussing","year":"2000","journal-title":"Cytometry"},{"issue":"11","key":"17","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.4049\/jimmunol.1302539","article-title":"CD4+ T-cells from human neonates and infants are poised spontaneously to run a nonclassical IL-4 program","volume":"192","author":"Brunner-Weinzierl","year":"2014","journal-title":"Journal of immunology"},{"issue":"18","key":"18","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1182\/blood-2009-05-219584","article-title":"Epigenetic mechanisms of regulation of Foxp3 expression","volume":"114","author":"Bromberg","year":"2009","journal-title":"Blood"},{"issue":"2","key":"19","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1067\/mai.2002.121145","article-title":"Histone deacetylation inhibits IL4 gene expression in T-cells","volume":"109","author":"Georas","year":"2002","journal-title":"The Journal of allergy and clinical immunology"},{"issue":"8","key":"20","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1182\/blood-2002-08-2499","article-title":"A nonsecreted variant of interleukin-4 is associated with apoptosis: implication for the T helper-2 polarization in HIV infection","volume":"101","author":"Gougeon","year":"2003","journal-title":"Blood"},{"issue":"3","key":"21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1021\/pr025586y","article-title":"Structural and functional properties of IL-4delta2, an alternative splice variant of human IL-4","volume":"2","author":"DuBuske","year":"2003","journal-title":"Journal of proteome research"},{"issue":"3","key":"22","first-page":"573","article-title":"Valproic acid induces non-apoptotic cell death mechanisms in multiple myeloma cell lines","volume":"30","author":"Berchem","year":"2007","journal-title":"International journal of oncology"},{"issue":"2","key":"23","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/jnc.13029","article-title":"Valproic acid induces neuronal cell death through a novel calpain-dependent necroptosis pathway","volume":"133","author":"Aurelian","year":"2015","journal-title":"Journal of neurochemistry"},{"key":"24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12964-015-0103-0","article-title":"Homoharringtonine, a clinically approved anti-leukemia drug, sensitizes tumor cells for TRAIL-induced necroptosis","volume":"13","author":"Adam","year":"2015","journal-title":"Cell communication and signaling"},{"key":"25","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1478-811X-11-76","article-title":"The proteases HtrA2\/Omi and UCH-L1 regulate TNF-induced necroptosis","volume":"11","author":"Adam","year":"2013","journal-title":"Cell communication and signaling"},{"issue":"3","key":"26","first-page":"379","article-title":"IL-4 is able to reverse the CD2-mediated negative apoptotic signal to CD4-CD8- alpha beta and\/or gamma delta T lymphocytes","volume":"86","author":"Bertotto","year":"1995","journal-title":"Immunology"},{"issue":"2","key":"27","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/cmi.2015.07","article-title":"A new effect of IL-4 on human gammadelta T cells: promoting regulatory Vdelta1 T cells via IL-10 production and inhibiting function of Vdelta2 T cells","volume":"13","author":"He","year":"2016","journal-title":"Cellular & molecular immunology"},{"key":"28","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/1471-2164-13-424","article-title":"H3K9 and H3K14 acetylation co-occur at many gene regulatory elements, while H3K14ac marks a subset of inactive inducible promoters in mouse embryonic stem cells","volume":"13","author":"Tora","year":"2012","journal-title":"BMC genomics"},{"issue":"9","key":"29","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1101\/gr.136184.111","article-title":"ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia","volume":"22","author":"Epstein","year":"2012","journal-title":"Genome research"},{"issue":"38","key":"30","doi-asserted-by":"crossref","first-page":"32569","DOI":"10.1074\/jbc.M503201200","article-title":"Histone deacetylase inhibitors suppress the induction of c-Jun and its target genes including COX-2","volume":"280","author":"Subbaramaiah","year":"2005","journal-title":"The Journal of biological chemistry"},{"issue":"2","key":"31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4161\/auto.7.2.14212","article-title":"zVAD-induced autophagic cell death requires c-Src-dependent ERK and JNK activation and reactive oxygen species generation","volume":"7","author":"Lin","year":"2011","journal-title":"Autophagy"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Behrens, Sabapathy, Graef, Cleary, Crabtree, Wagner. Jun N-terminal kinase 2 modulates thymocyte apoptosis and T-cell activation through c-Jun and nuclear factor of activated T-cell (NF-AT). Proceedings of the National Academy of Sciences of the United States of America. 2001. 98(4):pp. 1769\u20131774.","DOI":"10.1073\/pnas.98.4.1769"},{"issue":"8","key":"33","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/cdd.2010.58","article-title":"Cracking the death code: apoptosis-related histone modifications","volume":"17","author":"Joseph","year":"2010","journal-title":"Cell death and differentiation"},{"key":"34","first-page":"2010","article-title":"Molecular and therapeutic potential and toxicity of valproic acid","author":"Diederich","year":"2010","journal-title":"Journal of biomedicine & biotechnology"},{"issue":"2","key":"35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/sj.bjc.6603851","article-title":"Valproic acid (VPA) in patients with refractory advanced cancer: a dose escalating phase I clinical trial","volume":"97","author":"Jager","year":"2007","journal-title":"British journal of cancer"},{"issue":"3","key":"36","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1593\/tlo.08136","article-title":"A Phase II Clinical Trial of Oral Valproic Acid in Patients with Castration-Resistant Prostate Cancers Using an Intensive Biomarker Sampling Strategy","volume":"1","author":"Vogelzang","year":"2008","journal-title":"Translational oncology"},{"issue":"7","key":"37","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1158\/1078-0432.CCR-08-1930","article-title":"Clinical and biological effects of valproic acid as a histone deacetylase inhibitor on tumor and surrogate tissues: phase I\/II trial of valproic acid and epirubicin\/FEC","volume":"15","author":"Sullivan","year":"2009","journal-title":"Clinical cancer research"},{"issue":"3","key":"38","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1158\/1078-0432.CCR-10-0738","article-title":"Phase 1 study of valproic acid in pediatric patients with refractory solid or CNS tumors: a children's oncology group report","volume":"17","author":"Blaney","year":"2011","journal-title":"Clinical cancer research"},{"key":"39","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1186\/1471-2407-14-875","article-title":"Phase 1\/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid--short Radiotherapy--rectum 3rd trial)","volume":"14","author":"Bianco","year":"2014","journal-title":"BMC cancer"},{"issue":"6","key":"40","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/SLA.0b013e3181758d0e","article-title":"Valproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cells","volume":"247","author":"Chen","year":"2008","journal-title":"Annals of surgery"},{"key":"41","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/1756-9966-29-149","article-title":"Effects of valproic acid on the cell cycle and apoptosis through acetylation of histone and tubulin in a scirrhous gastric cancer cell line","volume":"29","author":"Hirakawa","year":"2010","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"1","key":"42","first-page":"7","article-title":"Valproic acid suppresses growth and enhances cisplatin cytotoxicity to larynx cancer cells","volume":"6","author":"Stepulak","year":"2014","journal-title":"Head Neck Oncology"},{"issue":"11","key":"43","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nri3743","article-title":"Regulated cell death and inflammation: an auto-amplification loop causes organ failure","volume":"14","author":"Anders","year":"2014","journal-title":"Nature reviews Immunology"},{"issue":"5","key":"44","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1074\/jbc.M005390200","article-title":"Induction of rapid histone degradation by the cytotoxic T lymphocyte protease Granzyme A","volume":"276","author":"Lieberman","year":"2001","journal-title":"The Journal of biological chemistry"},{"issue":"3","key":"45","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1139\/o01-031","article-title":"Histone modifications and apoptosis: cause or consequence?","volume":"79","author":"Th'ng","year":"2001","journal-title":"Biochemistry and cell biology = Biochimie et biologie cellulaire"},{"issue":"34","key":"46","doi-asserted-by":"crossref","first-page":"28656","DOI":"10.1074\/jbc.M112.356584","article-title":"The antiepileptic drug valproic acid restores T-cell homeostasis and ameliorates pathogenesis of experimental autoimmune encephalomyelitis","volume":"287","author":"Xie","year":"2012","journal-title":"The Journal of biological chemistry"},{"issue":"12","key":"47","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1093\/molbev\/msp197","article-title":"Evolutionary trajectories of primate genes involved in HIV pathogenesis","volume":"26","author":"Telenti","year":"2009","journal-title":"Molecular biology and evolution"},{"key":"48","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/1471-2148-10-223","article-title":"Diversifying selection and functional analysis of interleukin-4 suggests antagonism-driven evolution at receptor-binding interfaces","volume":"10","author":"Bix","year":"2010","journal-title":"BMC evolutionary biology"},{"issue":"17","key":"49","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1128\/MCB.00048-14","article-title":"Cell fate decisions regulated by K63 ubiquitination of tumor necrosis factor receptor 1","volume":"34","author":"Schutze","year":"2014","journal-title":"Molecular and cellular biology"},{"issue":"5","key":"50","first-page":"1283","article-title":"Dental implants stimulate expression of Interleukin-8 and its receptor in human blood--an in vitro approach","volume":"100","author":"Kern","year":"2012","journal-title":"Journal of biomedical materials research Part B, Applied biomaterials"},{"issue":"Database issue","key":"51","first-page":"D447","article-title":"STRING v10: protein-protein interaction networks, integrated over the tree of life","volume":"43","author":"von Mering","year":"2015","journal-title":"Nucleic acids research"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11462","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T13:12:04Z","timestamp":1589289124000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,20]]},"references-count":51,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2016,10,4]]}},"alternative-id":["11462","27556516"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.11462","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,20]]}}}